T\u00fcrk-Alman g\u00f6\u00e7menler taraf\u0131ndan kurulan ve mRNA teknolojisine dayal\u0131 COVID-19 a\u015f\u0131s\u0131yla \u00fcnlenen Alman biyoteknoloji \u015firketi BioNTech, deneysel s\u0131tma a\u015f\u0131s\u0131n\u0131n insanlarda de\u011ferlendirilmesi i\u00e7in erken a\u015fama klinik deneme \u00e7al\u0131\u015fmas\u0131 ba\u015flatt\u0131\u011f\u0131n\u0131 duyurdu.<\/p>\n
A\u015fama 1 denemesinin, a\u015f\u0131 aday\u0131n\u0131 \u00fc\u00e7 doz seviyesinde de\u011ferlendirmek i\u00e7in Amerika Birle\u015fik Devletleri’nde s\u0131tma \u00f6yk\u00fcs\u00fc olmayan 60 g\u00f6n\u00fcll\u00fcy\u00fc kaydetmesi bekleniyor.<\/p>\n
BioNTech’in s\u0131tma projesinin ilk a\u015f\u0131 aday\u0131 olan BNT165b1, Afrika’da da a\u015f\u0131 \u00fcretimi kuracak.<\/p>\n
\u00c7aba, her y\u0131l Afrika’da 600.000’den fazla \u00e7ocu\u011fu \u00f6ld\u00fcren sivrisinek kaynakl\u0131 hastal\u0131\u011f\u0131 ele almaya odaklanan birka\u00e7 giri\u015fimden biri. S\u0131tma parazitinin karma\u015f\u0131k yap\u0131s\u0131 ve ya\u015fam d\u00f6ng\u00fcs\u00fc, a\u015f\u0131 geli\u015ftirme \u00e7abalar\u0131n\u0131 uzun s\u00fcredir engellemektedir.<\/p>\n
Onlarca y\u0131ll\u0131k \u00e7al\u0131\u015fman\u0131n ard\u0131ndan, \u0130ngiliz ila\u00e7 \u00fcreticisi GSK taraf\u0131ndan yap\u0131lan, onaylanm\u0131\u015f tek s\u0131tma a\u015f\u0131s\u0131 Mosquirix, bu y\u0131l D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (WHO) taraf\u0131ndan onayland\u0131. Yine de, finansman ve ticari potansiyel eksikli\u011fi, GSK’n\u0131n gerekti\u011fi kadar doz \u00fcretme kapasitesini engelledi.<\/p>\n
Merakla izlenen bir di\u011fer \u00e7al\u0131\u015fma da Oxford \u00dcniversitesi’nden bir s\u0131tma a\u015f\u0131s\u0131. Orta a\u015fama deneme verileri Eyl\u00fcl ay\u0131nda yay\u0131nland\u0131.<\/p>\n
Do\u011frudan bir kar\u015f\u0131la\u015ft\u0131rma yap\u0131lmad\u0131, ancak baz\u0131 bilim adamlar\u0131 Oxford a\u015f\u0131s\u0131n\u0131n Mosquirix’ten bir ad\u0131m \u00f6nde oldu\u011funu ve daha uzun ba\u011f\u0131\u015f\u0131kl\u0131k sa\u011flad\u0131\u011f\u0131n\u0131 \u00f6ne s\u00fcr\u00fcyor.<\/p>\n
BioNTech’in s\u0131tma a\u015f\u0131s\u0131 \u00e7abas\u0131, insan v\u00fccudunu patojenin bir par\u00e7as\u0131 olan bir protein yapmaya te\u015fvik ederek bir ba\u011f\u0131\u015f\u0131kl\u0131k tepkisini tetikleyerek h\u0131zla COVID-19 a\u015f\u0131lar\u0131 geli\u015ftirmek i\u00e7in pandemi s\u0131ras\u0131nda kullan\u0131lan mRNA teknolojisine dayanmaktad\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"
T\u00fcrk-Alman g\u00f6\u00e7menler taraf\u0131ndan kurulan ve mRNA teknolojisine dayal\u0131 COVID-19 a\u015f\u0131s\u0131yla \u00fcnlenen Alman biyoteknoloji \u015firketi BioNTech, deneysel s\u0131tma a\u015f\u0131s\u0131n\u0131n insanlarda de\u011ferlendirilmesi i\u00e7in erken a\u015fama klinik deneme \u00e7al\u0131\u015fmas\u0131 ba\u015flatt\u0131\u011f\u0131n\u0131 duyurdu. A\u015fama 1 denemesinin, a\u015f\u0131 aday\u0131n\u0131 \u00fc\u00e7 doz seviyesinde de\u011ferlendirmek i\u00e7in Amerika Birle\u015fik Devletleri’nde s\u0131tma \u00f6yk\u00fcs\u00fc olmayan 60 g\u00f6n\u00fcll\u00fcy\u00fc kaydetmesi bekleniyor. BioNTech’in s\u0131tma projesinin ilk a\u015f\u0131 aday\u0131 olan …<\/p>\n","protected":false},"author":4,"featured_media":50190,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-50189","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/adanaseshaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/50189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adanaseshaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adanaseshaber.com.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adanaseshaber.com.tr\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/adanaseshaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=50189"}],"version-history":[{"count":1,"href":"https:\/\/adanaseshaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/50189\/revisions"}],"predecessor-version":[{"id":50191,"href":"https:\/\/adanaseshaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/50189\/revisions\/50191"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adanaseshaber.com.tr\/index.php?rest_route=\/wp\/v2\/media\/50190"}],"wp:attachment":[{"href":"https:\/\/adanaseshaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=50189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adanaseshaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=50189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adanaseshaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=50189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}